Stockreport

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering [Yahoo! Finance]

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF CARLSBAD, Calif., November 20, 2024 BUSINESS WIRE Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allo [Read more]